Company: HROW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000925
Chunk: 505

Company: HARROW, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1B
Chunk 505
---
ization, and asset sales and impairments, net as not all such information has been accounted for at the
    segment level, or such information has not been used by all segments.

Segment net revenues, segment operating expenses
and segment contribution information consisted of the following:

SCHEDULE
OF SEGMENT NET REVENUES

    Branded  
    ImprimisRx  
    Consolidated 

    Year Ended December 31, 2024 

    Branded  
    ImprimisRx  
    Consolidated 
  
    Product sales, net 
    $115,120,000  
    $83,499,000  
    $198,619,000 
  
    Other revenues 
     995,000  
     -  
     995,000 
  
    Total revenues 
     116,115,000  
     83,499,000  
     199,614,000 
  
    Cost of sales 
     (21,667,000) 
     (27,578,000) 
     (49,245,000)
  
    Gross profit 
     94,448,000  
     55,921,000  
     150,369,000 
  
    Operating expenses: 

    Selling, general and administrative 
     62,301,000  
     23,607,000  
     85,908,000 
  
    Research and development 
     2,890,000  
     386,000  
     3,276,000 
  
    Segment contribution 
    $29,257,000  
    $31,928,000  
     61,185,000 
  
    Corporate 

     43,409,000 
  
    Research and development 

     8,954,000 
  
    Income from operations 

    $8,822,000 

    Branded  
    ImprimisRx  
    Consolidated 

    Year Ended December 31, 2023 

    Branded  
    ImprimisRx  
    Consolidated 
  
    Product sales, net 
    $37,512,000  
    $79,935,000  
    $117,447,000 
  
    Other revenues 
     12,746,000  
     -  
     12,746,000